Skip to content

Comparison of Air QTM Intubating Airway Versus Ambu-Aura Intubating Laryngeal Mask

Comparison of Air QTM Intubating Airway Versus Ambu-Aura Intubating Laryngeal Mask Obese Patients Under General Anaesthesia.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04195035
Enrollment
40
Registered
2019-12-11
Start date
2019-12-10
Completion date
2020-01-15
Last updated
2019-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway Management, Obesity

Keywords

obesity, Air QTM intubating airway, Ambu-Aura intubating laryngeal mask

Brief summary

Supraglottic airway devices are important tools for airway management. Supraglottic airway devices have been introduced into brief surgical interventions because they are less invasive than intubation and safer than mask to maintain the patency of airway after induction of anesthesia. They are inserted via the oral route and can be used in emergency conditions when tracheal intubation and mask anesthesia are challenging. Air Q intubating airway and Ambu Aura intubating laryngeal mask are two Supraglottic airway devices that are widely used. Aim of the work is to compare Air-Q intubating laryngeal airway versus Ambu-Aura intubating laryngeal mask regarding sealing pressure and Fiberoptic intubation in class II obese patients.

Detailed description

Randomized comparative trial that will be performed in Kasr Al Ainy hospital, Cairo University, Cairo, Egypt.ASA II patients from 20 to 50 years of age, undergoing minor surgry were included in this study. 40 patients will be allocated into 2 equal groups using computerized software and enclosed in sealed opaque envelopes: GQ ( n=20 ): Where Air-Q intubating laryngeal airway will be used for ventilation & intubation through fiberoptic bronchoscope. GA ( n=20 ): Where Ambu-Aura intubating laryngeal mask will be used for ventilation & intubation through fiberoptic bronchscope.

Interventions

DEVICEAir-Q intubating laryngeal airway

Air-Q intubating laryngeal airway will be used for ventilation & intubation through fiberoptic bronchoscope.

DEVICEAmbu-Aura intubating laryngeal mask

Ambu-Aura intubating laryngeal mask will be used for ventilation & intubation through fiberoptic bronchscope.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients aged 18-65 years old. * Sex: both genders. * With American society of anaesthesiologists (ASA) physical activity II. * Scheduled for elective surgery under general anaesthesia requiring endotracheal tube. * Class II obese patients (BMI 34.9 - 39.9 kg/m2). * Surgery: short time procedures ≥ 60 minutes, ≤ 120 minutes e.g.: breast surgery, elbow or foot surgery.

Exclusion criteria

* • Patient refusal. * Patients with any respiratory tract abnormalities as laryngeal masses & facial deformities as fracture mandible. * Patients with risk of pulmonary aspiration as in full stomach patients. * Patients at risk of regurgitation of gastric content as in gastroesophageal reflux disease (GERD) and pregnant females. * Emergency operation. * Patients with obstructive sleep apnea. * Patients prepared for laparotomy or laparoscopic procedures. * Patients with risk of bleeding.

Design outcomes

Primary

MeasureTime frameDescription
airway seal pressure1 minuteMeasuring the seal pressure above which the oropharyngeal leak through the supraglottic device will occur (1 minute after confirmation of successful insertion).

Secondary

MeasureTime frameDescription
Success rate1 minuteSuccess rate of device insertion
arterial blood pressure2 hourssystolic and diastolic arterial blood pressure. • Stress response related to the device used.
heart rate2 hours• Stress response related to the device used
Laryngeal view grade.1 minuteGrade 1: only larynx was seen, Grade 2: larynx plus the posterior surface of epiglottis were seen. Grade 3: larynx and anterior tip of epiglottis were seen with \<50% visual obstruction of larynx. Grade 4: epiglottis down folded and its anterior surface were seen with \>50% visual field obstruction. Grade 5: complete down folding of epiglottis and the larynx could not be seen directly
Success rate of intubation by fiberoptic bronchoscope1 minuteThe success of the ventilation will be determined based on visible chest expansion, adequate tidal volume and drawing of 6 successive ETCO2 waves.

Countries

Egypt

Contacts

Primary ContactBassant abdelhamid
bassantmohamed197@yahoo.com01224254012
Backup ContactInas Farouk
inasfarouk@hotmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026